The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis
- PMID: 32198274
- DOI: 10.1183/13993003.00224-2020
The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis
Conflict of interest statement
Conflict of interest: J.P. Cegielski has nothing to disclose. Conflict of interest: P. Nahid has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose.
Comment on
-
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.Eur Respir J. 2020 Mar 20;55(3):1901467. doi: 10.1183/13993003.01467-2019. Print 2020 Mar. Eur Respir J. 2020. PMID: 31862767